 | • レポートコード：MRC2-11QY02108 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は成人・青年期用ワクチンのグローバル市場について調査・分析したレポートです。種類別（季節ワクチン、旅行ワクチン）市場規模、用途別（成人、青年）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別成人・青年期用ワクチンの競争状況、市場シェア ・世界の成人・青年期用ワクチン市場：種類別市場規模 2015年-2020年（季節ワクチン、旅行ワクチン） ・世界の成人・青年期用ワクチン市場：種類別市場規模予測 2021年-2026年（季節ワクチン、旅行ワクチン） ・世界の成人・青年期用ワクチン市場：用途別市場規模 2015年-2020年（成人、青年） ・世界の成人・青年期用ワクチン市場：用途別市場規模予測 2021年-2026年（成人、青年） ・北米の成人・青年期用ワクチン市場分析：米国、カナダ ・ヨーロッパの成人・青年期用ワクチン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの成人・青年期用ワクチン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の成人・青年期用ワクチン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの成人・青年期用ワクチン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Merck、GlaxoSmithKline、Novartis、Pfizer、Sanofi Aventis ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Vaccines are biological agents that helps the immune system to prepare for an infection against harmful pathogens.
With increasing prevalence of various cancer (cervical cancer) and infectious diseases (hepatitis A & B) accentuates the growth of the global adult and adolescent vaccines market. In addition, government initiatives for adult and adolescent vaccines also demands the market growth. The high cost of these vaccines might restrict the global adult and adolescent vaccines market.
Market Analysis and Insights: Global Adult and Adolescent Vaccines Market
The global Adult and Adolescent Vaccines market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Adult and Adolescent Vaccines Scope and Market Size
Adult and Adolescent Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Adult and Adolescent Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Adult and Adolescent Vaccines market is segmented into
Seasonal Vaccines
Travel Vaccines
Segment by Application, the Adult and Adolescent Vaccines market is segmented into
Adult
Adolescent
Regional and Country-level Analysis
The Adult and Adolescent Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Adult and Adolescent Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Adult and Adolescent Vaccines Market Share Analysis
Adult and Adolescent Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Adult and Adolescent Vaccines business, the date to enter into the Adult and Adolescent Vaccines market, Adult and Adolescent Vaccines product introduction, recent developments, etc.
The major vendors covered:
Merck
GlaxoSmithKline
Novartis
Pfizer
Sanofi Aventis
…
1 Study Coverage
1.1 Adult and Adolescent Vaccines Product Introduction
1.2 Market Segments
1.3 Key Adult and Adolescent Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Adult and Adolescent Vaccines Market Size Growth Rate by Type
1.4.2 Seasonal Vaccines
1.4.3 Travel Vaccines
1.5 Market by Application
1.5.1 Global Adult and Adolescent Vaccines Market Size Growth Rate by Application
1.5.2 Adult
1.5.3 Adolescent
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Adult and Adolescent Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Adult and Adolescent Vaccines Revenue 2015-2026
2.1.2 Global Adult and Adolescent Vaccines Sales 2015-2026
2.2 Global Adult and Adolescent Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Adult and Adolescent Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Adult and Adolescent Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Adult and Adolescent Vaccines Competitor Landscape by Players
3.1 Adult and Adolescent Vaccines Sales by Manufacturers
3.1.1 Adult and Adolescent Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Adult and Adolescent Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Adult and Adolescent Vaccines Revenue by Manufacturers
3.2.1 Adult and Adolescent Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Adult and Adolescent Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Adult and Adolescent Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Adult and Adolescent Vaccines Revenue in 2019
3.2.5 Global Adult and Adolescent Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Adult and Adolescent Vaccines Price by Manufacturers
3.4 Adult and Adolescent Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Adult and Adolescent Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Adult and Adolescent Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Adult and Adolescent Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Adult and Adolescent Vaccines Market Size by Type (2015-2020)
4.1.1 Global Adult and Adolescent Vaccines Sales by Type (2015-2020)
4.1.2 Global Adult and Adolescent Vaccines Revenue by Type (2015-2020)
4.1.3 Adult and Adolescent Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Adult and Adolescent Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Adult and Adolescent Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Adult and Adolescent Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Adult and Adolescent Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Adult and Adolescent Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Adult and Adolescent Vaccines Market Size by Application (2015-2020)
5.1.1 Global Adult and Adolescent Vaccines Sales by Application (2015-2020)
5.1.2 Global Adult and Adolescent Vaccines Revenue by Application (2015-2020)
5.1.3 Adult and Adolescent Vaccines Price by Application (2015-2020)
5.2 Adult and Adolescent Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Adult and Adolescent Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Adult and Adolescent Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Adult and Adolescent Vaccines Price Forecast by Application (2021-2026)
6 North America
6.1 North America Adult and Adolescent Vaccines by Country
6.1.1 North America Adult and Adolescent Vaccines Sales by Country
6.1.2 North America Adult and Adolescent Vaccines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Adult and Adolescent Vaccines Market Facts & Figures by Type
6.3 North America Adult and Adolescent Vaccines Market Facts & Figures by Application
7 Europe
7.1 Europe Adult and Adolescent Vaccines by Country
7.1.1 Europe Adult and Adolescent Vaccines Sales by Country
7.1.2 Europe Adult and Adolescent Vaccines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Adult and Adolescent Vaccines Market Facts & Figures by Type
7.3 Europe Adult and Adolescent Vaccines Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Adult and Adolescent Vaccines by Region
8.1.1 Asia Pacific Adult and Adolescent Vaccines Sales by Region
8.1.2 Asia Pacific Adult and Adolescent Vaccines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Adult and Adolescent Vaccines Market Facts & Figures by Type
8.3 Asia Pacific Adult and Adolescent Vaccines Market Facts & Figures by Application
9 Latin America
9.1 Latin America Adult and Adolescent Vaccines by Country
9.1.1 Latin America Adult and Adolescent Vaccines Sales by Country
9.1.2 Latin America Adult and Adolescent Vaccines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Adult and Adolescent Vaccines Market Facts & Figures by Type
9.3 Central & South America Adult and Adolescent Vaccines Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Adult and Adolescent Vaccines by Country
10.1.1 Middle East and Africa Adult and Adolescent Vaccines Sales by Country
10.1.2 Middle East and Africa Adult and Adolescent Vaccines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Adult and Adolescent Vaccines Market Facts & Figures by Type
10.3 Middle East and Africa Adult and Adolescent Vaccines Market Facts & Figures by Application
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description and Business Overview
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Adult and Adolescent Vaccines Products Offered
11.1.5 Merck Related Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Corporation Information
11.2.2 GlaxoSmithKline Description and Business Overview
11.2.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GlaxoSmithKline Adult and Adolescent Vaccines Products Offered
11.2.5 GlaxoSmithKline Related Developments
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Description and Business Overview
11.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Novartis Adult and Adolescent Vaccines Products Offered
11.3.5 Novartis Related Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Description and Business Overview
11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Pfizer Adult and Adolescent Vaccines Products Offered
11.4.5 Pfizer Related Developments
11.5 Sanofi Aventis
11.5.1 Sanofi Aventis Corporation Information
11.5.2 Sanofi Aventis Description and Business Overview
11.5.3 Sanofi Aventis Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sanofi Aventis Adult and Adolescent Vaccines Products Offered
11.5.5 Sanofi Aventis Related Developments
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description and Business Overview
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Adult and Adolescent Vaccines Products Offered
11.1.5 Merck Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Adult and Adolescent Vaccines Market Estimates and Projections by Region
12.1.1 Global Adult and Adolescent Vaccines Sales Forecast by Regions 2021-2026
12.1.2 Global Adult and Adolescent Vaccines Revenue Forecast by Regions 2021-2026
12.2 North America Adult and Adolescent Vaccines Market Size Forecast (2021-2026)
12.2.1 North America: Adult and Adolescent Vaccines Sales Forecast (2021-2026)
12.2.2 North America: Adult and Adolescent Vaccines Revenue Forecast (2021-2026)
12.2.3 North America: Adult and Adolescent Vaccines Market Size Forecast by Country (2021-2026)
12.3 Europe Adult and Adolescent Vaccines Market Size Forecast (2021-2026)
12.3.1 Europe: Adult and Adolescent Vaccines Sales Forecast (2021-2026)
12.3.2 Europe: Adult and Adolescent Vaccines Revenue Forecast (2021-2026)
12.3.3 Europe: Adult and Adolescent Vaccines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Adult and Adolescent Vaccines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Adult and Adolescent Vaccines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Adult and Adolescent Vaccines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Adult and Adolescent Vaccines Market Size Forecast by Region (2021-2026)
12.5 Latin America Adult and Adolescent Vaccines Market Size Forecast (2021-2026)
12.5.1 Latin America: Adult and Adolescent Vaccines Sales Forecast (2021-2026)
12.5.2 Latin America: Adult and Adolescent Vaccines Revenue Forecast (2021-2026)
12.5.3 Latin America: Adult and Adolescent Vaccines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Adult and Adolescent Vaccines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Adult and Adolescent Vaccines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Adult and Adolescent Vaccines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Adult and Adolescent Vaccines Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Adult and Adolescent Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Adult and Adolescent Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Adult and Adolescent Vaccines Market Segments
Table 2. Ranking of Global Top Adult and Adolescent Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Adult and Adolescent Vaccines Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Seasonal Vaccines
Table 5. Major Manufacturers of Travel Vaccines
Table 6. Global Adult and Adolescent Vaccines Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Adult and Adolescent Vaccines Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Adult and Adolescent Vaccines Sales by Regions 2015-2020 (K Units)
Table 9. Global Adult and Adolescent Vaccines Sales Market Share by Regions (2015-2020)
Table 10. Global Adult and Adolescent Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Adult and Adolescent Vaccines Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Adult and Adolescent Vaccines Sales Share by Manufacturers (2015-2020)
Table 13. Global Adult and Adolescent Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Adult and Adolescent Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adult and Adolescent Vaccines as of 2019)
Table 15. Adult and Adolescent Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Adult and Adolescent Vaccines Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Adult and Adolescent Vaccines Price (2015-2020) (USD/Unit)
Table 18. Adult and Adolescent Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Adult and Adolescent Vaccines Product Type
Table 20. Date of International Manufacturers Enter into Adult and Adolescent Vaccines Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Adult and Adolescent Vaccines Sales by Type (2015-2020) (K Units)
Table 23. Global Adult and Adolescent Vaccines Sales Share by Type (2015-2020)
Table 24. Global Adult and Adolescent Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Adult and Adolescent Vaccines Revenue Share by Type (2015-2020)
Table 26. Adult and Adolescent Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Adult and Adolescent Vaccines Sales by Application (2015-2020) (K Units)
Table 28. Global Adult and Adolescent Vaccines Sales Share by Application (2015-2020)
Table 29. North America Adult and Adolescent Vaccines Sales by Country (2015-2020) (K Units)
Table 30. North America Adult and Adolescent Vaccines Sales Market Share by Country (2015-2020)
Table 31. North America Adult and Adolescent Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Adult and Adolescent Vaccines Revenue Market Share by Country (2015-2020)
Table 33. North America Adult and Adolescent Vaccines Sales by Type (2015-2020) (K Units)
Table 34. North America Adult and Adolescent Vaccines Sales Market Share by Type (2015-2020)
Table 35. North America Adult and Adolescent Vaccines Sales by Application (2015-2020) (K Units)
Table 36. North America Adult and Adolescent Vaccines Sales Market Share by Application (2015-2020)
Table 37. Europe Adult and Adolescent Vaccines Sales by Country (2015-2020) (K Units)
Table 38. Europe Adult and Adolescent Vaccines Sales Market Share by Country (2015-2020)
Table 39. Europe Adult and Adolescent Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Adult and Adolescent Vaccines Revenue Market Share by Country (2015-2020)
Table 41. Europe Adult and Adolescent Vaccines Sales by Type (2015-2020) (K Units)
Table 42. Europe Adult and Adolescent Vaccines Sales Market Share by Type (2015-2020)
Table 43. Europe Adult and Adolescent Vaccines Sales by Application (2015-2020) (K Units)
Table 44. Europe Adult and Adolescent Vaccines Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Adult and Adolescent Vaccines Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Adult and Adolescent Vaccines Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Adult and Adolescent Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Adult and Adolescent Vaccines Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Adult and Adolescent Vaccines Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Adult and Adolescent Vaccines Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Adult and Adolescent Vaccines Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Adult and Adolescent Vaccines Sales Market Share by Application (2015-2020)
Table 53. Latin America Adult and Adolescent Vaccines Sales by Country (2015-2020) (K Units)
Table 54. Latin America Adult and Adolescent Vaccines Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Adult and Adolescent Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Adult and Adolescent Vaccines Revenue Market Share by Country (2015-2020)
Table 57. Latin America Adult and Adolescent Vaccines Sales by Type (2015-2020) (K Units)
Table 58. Latin America Adult and Adolescent Vaccines Sales Market Share by Type (2015-2020)
Table 59. Latin America Adult and Adolescent Vaccines Sales by Application (2015-2020) (K Units)
Table 60. Latin America Adult and Adolescent Vaccines Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Adult and Adolescent Vaccines Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Adult and Adolescent Vaccines Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Adult and Adolescent Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Adult and Adolescent Vaccines Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Adult and Adolescent Vaccines Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Adult and Adolescent Vaccines Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Adult and Adolescent Vaccines Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Adult and Adolescent Vaccines Sales Market Share by Application (2015-2020)
Table 69. Merck Corporation Information
Table 70. Merck Description and Major Businesses
Table 71. Merck Adult and Adolescent Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Merck Product
Table 73. Merck Recent Development
Table 74. GlaxoSmithKline Corporation Information
Table 75. GlaxoSmithKline Description and Major Businesses
Table 76. GlaxoSmithKline Adult and Adolescent Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. GlaxoSmithKline Product
Table 78. GlaxoSmithKline Recent Development
Table 79. Novartis Corporation Information
Table 80. Novartis Description and Major Businesses
Table 81. Novartis Adult and Adolescent Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Novartis Product
Table 83. Novartis Recent Development
Table 84. Pfizer Corporation Information
Table 85. Pfizer Description and Major Businesses
Table 86. Pfizer Adult and Adolescent Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Pfizer Product
Table 88. Pfizer Recent Development
Table 89. Sanofi Aventis Corporation Information
Table 90. Sanofi Aventis Description and Major Businesses
Table 91. Sanofi Aventis Adult and Adolescent Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Sanofi Aventis Product
Table 93. Sanofi Aventis Recent Development
Table 94. Global Adult and Adolescent Vaccines Sales Forecast by Regions (2021-2026) (K Units)
Table 95. Global Adult and Adolescent Vaccines Sales Market Share Forecast by Regions (2021-2026)
Table 96. Global Adult and Adolescent Vaccines Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 97. Global Adult and Adolescent Vaccines Revenue Market Share Forecast by Regions (2021-2026)
Table 98. North America: Adult and Adolescent Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 99. North America: Adult and Adolescent Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 100. Europe: Adult and Adolescent Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 101. Europe: Adult and Adolescent Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 102. Asia Pacific: Adult and Adolescent Vaccines Sales Forecast by Region (2021-2026) (K Units)
Table 103. Asia Pacific: Adult and Adolescent Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 104. Latin America: Adult and Adolescent Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 105. Latin America: Adult and Adolescent Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 106. Middle East and Africa: Adult and Adolescent Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 107. Middle East and Africa: Adult and Adolescent Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 108. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 109. Key Challenges
Table 110. Market Risks
Table 111. Main Points Interviewed from Key Adult and Adolescent Vaccines Players
Table 112. Adult and Adolescent Vaccines Customers List
Table 113. Adult and Adolescent Vaccines Distributors List
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Adult and Adolescent Vaccines Product Picture
Figure 2. Global Adult and Adolescent Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Seasonal Vaccines Product Picture
Figure 4. Travel Vaccines Product Picture
Figure 5. Global Adult and Adolescent Vaccines Sales Market Share by Application in 2020 & 2026
Figure 6. Adult
Figure 7. Adolescent
Figure 8. Adult and Adolescent Vaccines Report Years Considered
Figure 9. Global Adult and Adolescent Vaccines Market Size 2015-2026 (US$ Million)
Figure 10. Global Adult and Adolescent Vaccines Sales 2015-2026 (K Units)
Figure 11. Global Adult and Adolescent Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Adult and Adolescent Vaccines Sales Market Share by Region (2015-2020)
Figure 13. Global Adult and Adolescent Vaccines Sales Market Share by Region in 2019
Figure 14. Global Adult and Adolescent Vaccines Revenue Market Share by Region (2015-2020)
Figure 15. Global Adult and Adolescent Vaccines Revenue Market Share by Region in 2019
Figure 16. Global Adult and Adolescent Vaccines Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Adult and Adolescent Vaccines Revenue in 2019
Figure 18. Adult and Adolescent Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Adult and Adolescent Vaccines Sales Market Share by Type (2015-2020)
Figure 20. Global Adult and Adolescent Vaccines Sales Market Share by Type in 2019
Figure 21. Global Adult and Adolescent Vaccines Revenue Market Share by Type (2015-2020)
Figure 22. Global Adult and Adolescent Vaccines Revenue Market Share by Type in 2019
Figure 23. Global Adult and Adolescent Vaccines Market Share by Price Range (2015-2020)
Figure 24. Global Adult and Adolescent Vaccines Sales Market Share by Application (2015-2020)
Figure 25. Global Adult and Adolescent Vaccines Sales Market Share by Application in 2019
Figure 26. Global Adult and Adolescent Vaccines Revenue Market Share by Application (2015-2020)
Figure 27. Global Adult and Adolescent Vaccines Revenue Market Share by Application in 2019
Figure 28. North America Adult and Adolescent Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 29. North America Adult and Adolescent Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Adult and Adolescent Vaccines Sales Market Share by Country in 2019
Figure 31. North America Adult and Adolescent Vaccines Revenue Market Share by Country in 2019
Figure 32. U.S. Adult and Adolescent Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.S. Adult and Adolescent Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Adult and Adolescent Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 35. Canada Adult and Adolescent Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Adult and Adolescent Vaccines Market Share by Type in 2019
Figure 37. North America Adult and Adolescent Vaccines Market Share by Application in 2019
Figure 38. Europe Adult and Adolescent Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 39. Europe Adult and Adolescent Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Adult and Adolescent Vaccines Sales Market Share by Country in 2019
Figure 41. Europe Adult and Adolescent Vaccines Revenue Market Share by Country in 2019
Figure 42. Germany Adult and Adolescent Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 43. Germany Adult and Adolescent Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Adult and Adolescent Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 45. France Adult and Adolescent Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Adult and Adolescent Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 47. U.K. Adult and Adolescent Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Adult and Adolescent Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 49. Italy Adult and Adolescent Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Adult and Adolescent Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 51. Russia Adult and Adolescent Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Adult and Adolescent Vaccines Market Share by Type in 2019
Figure 53. Europe Adult and Adolescent Vaccines Market Share by Application in 2019
Figure 54. Asia Pacific Adult and Adolescent Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 55. Asia Pacific Adult and Adolescent Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Adult and Adolescent Vaccines Sales Market Share by Region in 2019
Figure 57. Asia Pacific Adult and Adolescent Vaccines Revenue Market Share by Region in 2019
Figure 58. China Adult and Adolescent Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 59. China Adult and Adolescent Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Adult and Adolescent Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 61. Japan Adult and Adolescent Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Adult and Adolescent Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 63. South Korea Adult and Adolescent Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Adult and Adolescent Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 65. India Adult and Adolescent Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Adult and Adolescent Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 67. Australia Adult and Adolescent Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Adult and Adolescent Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 69. Taiwan Adult and Adolescent Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Adult and Adolescent Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 71. Indonesia Adult and Adolescent Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Adult and Adolescent Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 73. Thailand Adult and Adolescent Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Adult and Adolescent Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 75. Malaysia Adult and Adolescent Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Adult and Adolescent Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 77. Philippines Adult and Adolescent Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Adult and Adolescent Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 79. Vietnam Adult and Adolescent Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Adult and Adolescent Vaccines Market Share by Type in 2019
Figure 81. Asia Pacific Adult and Adolescent Vaccines Market Share by Application in 2019
Figure 82. Latin America Adult and Adolescent Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 83. Latin America Adult and Adolescent Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Adult and Adolescent Vaccines Sales Market Share by Country in 2019
Figure 85. Latin America Adult and Adolescent Vaccines Revenue Market Share by Country in 2019
Figure 86. Mexico Adult and Adolescent Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 87. Mexico Adult and Adolescent Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Adult and Adolescent Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 89. Brazil Adult and Adolescent Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Adult and Adolescent Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 91. Argentina Adult and Adolescent Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Adult and Adolescent Vaccines Market Share by Type in 2019
Figure 93. Latin America Adult and Adolescent Vaccines Market Share by Application in 2019
Figure 94. Middle East and Africa Adult and Adolescent Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 95. Middle East and Africa Adult and Adolescent Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Adult and Adolescent Vaccines Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Adult and Adolescent Vaccines Revenue Market Share by Country in 2019
Figure 98. Turkey Adult and Adolescent Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 99. Turkey Adult and Adolescent Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Adult and Adolescent Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 101. Saudi Arabia Adult and Adolescent Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Adult and Adolescent Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 103. U.A.E Adult and Adolescent Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Adult and Adolescent Vaccines Market Share by Type in 2019
Figure 105. Middle East and Africa Adult and Adolescent Vaccines Market Share by Application in 2019
Figure 106. North America Adult and Adolescent Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 107. North America Adult and Adolescent Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 108. Europe Adult and Adolescent Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 109. Europe Adult and Adolescent Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Asia Pacific Adult and Adolescent Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. Asia Pacific Adult and Adolescent Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Latin America Adult and Adolescent Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Latin America Adult and Adolescent Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Middle East and Africa Adult and Adolescent Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Middle East and Africa Adult and Adolescent Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Porter's Five Forces Analysis
Figure 117. Channels of Distribution
Figure 118. Distributors Profiles
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed
ワクチンデリバリーの世界市場（～2026年） Market Analysis and Insights: Global Vaccines Delivery Market The global Vaccines Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Vaccines Delivery Scope and Market Size Vaccines Delivery market is segmented b…- 予防的B型肝炎ウイルスワクチンの世界市場（～2026年） The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including liver cirrhosis and hepatocellular cancer. The increasing prevalence and incidence of hepatitis B infection is the dominant factor of driving the growth…
- 細菌ワクチンの世界市場（～2026年） Bacterial vaccines contain killed or attenuated bacteria that activate the immune system. Different types of bacterial vaccines include, capsular polysaccharide vaccines, toxoid vaccines, purified protein vaccines, live attenuated bacterial vaccines, and killed bacterial vaccines. Rise in prevalence…
- ワクチン・予防接種の世界市場（～2026年） Vaccination is the administration of antigenic material (avaccine) to stimulate an individual's immune system to develop adaptive immunity to a pathogen. Vaccines can prevent or ameliorate infectious disease. The increasing popularity of pediatric, travel, addiction, and pediatric combination vaccin…
- HIVワクチンの世界市場（～2026年） HIV Vaccine Market has been segmented on the basis of type which comprises of acute paronychia, chronic paronychia, candidal paronychia and pyogenic paronychia. On the basis of antibiotics, market is segmented into mupirocin ointment, fusidic acid ointment, gentamicin ointment, dicloxacillin and oth…